Boston Trust Walden Corp Has $49.99 Million Stock Position in Plexus Corp. $PLXS

Boston Trust Walden Corp decreased its position in Plexus Corp. (NASDAQ:PLXS) by 2.3% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 369,413 shares of the technology company’s stock after selling 8,835 shares during the period. Boston Trust Walden Corp owned approximately 1.36% of Plexus worth $49,985,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Xponance Inc. raised its position in shares of Plexus by 4.8% during the first quarter. Xponance Inc. now owns 2,315 shares of the technology company’s stock worth $297,000 after purchasing an additional 106 shares during the period. Inspire Investing LLC increased its stake in Plexus by 4.8% during the 1st quarter. Inspire Investing LLC now owns 2,682 shares of the technology company’s stock worth $344,000 after purchasing an additional 123 shares in the last quarter. Yousif Capital Management LLC increased its stake in Plexus by 1.2% during the 2nd quarter. Yousif Capital Management LLC now owns 10,117 shares of the technology company’s stock worth $1,369,000 after purchasing an additional 124 shares in the last quarter. Fox Run Management L.L.C. increased its stake in Plexus by 7.2% during the 1st quarter. Fox Run Management L.L.C. now owns 2,017 shares of the technology company’s stock worth $258,000 after purchasing an additional 135 shares in the last quarter. Finally, TD Private Client Wealth LLC increased its stake in Plexus by 31.5% during the 2nd quarter. TD Private Client Wealth LLC now owns 676 shares of the technology company’s stock worth $91,000 after purchasing an additional 162 shares in the last quarter. 94.45% of the stock is currently owned by institutional investors.

Plexus Trading Up 3.3%

Shares of Plexus stock opened at $138.06 on Tuesday. The stock has a market cap of $3.73 billion, a P/E ratio of 23.52 and a beta of 0.80. Plexus Corp. has a 12-month low of $103.43 and a 12-month high of $172.89. The business’s 50 day moving average is $137.98 and its 200-day moving average is $132.27. The company has a quick ratio of 0.74, a current ratio of 1.58 and a debt-to-equity ratio of 0.06.

Plexus (NASDAQ:PLXS) last issued its earnings results on Wednesday, July 23rd. The technology company reported $1.90 earnings per share for the quarter, topping analysts’ consensus estimates of $1.71 by $0.19. Plexus had a net margin of 4.04% and a return on equity of 12.33%. The business had revenue of $1.02 billion for the quarter, compared to the consensus estimate of $1.02 billion. During the same period in the previous year, the company earned $1.45 earnings per share. The firm’s revenue for the quarter was up 6.0% on a year-over-year basis. Plexus has set its Q4 2025 guidance at 1.820-1.970 EPS. Equities research analysts predict that Plexus Corp. will post 5.9 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Plexus news, CEO Todd P. Kelsey sold 1,500 shares of the company’s stock in a transaction that occurred on Wednesday, October 1st. The stock was sold at an average price of $143.70, for a total value of $215,550.00. Following the sale, the chief executive officer owned 69,214 shares in the company, valued at $9,946,051.80. This represents a 2.12% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, COO Oliver K. Mihm sold 2,102 shares of the business’s stock in a transaction that occurred on Friday, August 15th. The stock was sold at an average price of $130.43, for a total value of $274,163.86. Following the transaction, the chief operating officer directly owned 21,155 shares in the company, valued at $2,759,246.65. The trade was a 9.04% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 15,856 shares of company stock worth $2,142,440 in the last three months. Insiders own 1.76% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on PLXS. Wall Street Zen upgraded shares of Plexus from a “buy” rating to a “strong-buy” rating in a report on Saturday. Needham & Company LLC dropped their price target on Plexus from $162.00 to $158.00 and set a “buy” rating on the stock in a research note on Thursday, July 24th. Sidoti raised Plexus from a “neutral” rating to a “buy” rating and lifted their price target for the company from $135.00 to $150.00 in a research note on Friday, July 25th. Weiss Ratings reiterated a “hold (c+)” rating on shares of Plexus in a report on Wednesday, October 8th. Finally, Stifel Nicolaus set a $140.00 price target on Plexus in a research report on Thursday, July 24th. Three analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $155.60.

Plexus Company Profile

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.